Trial Profile
Dose escalation and cohort expansion safety study of intrathecal trastuzumab in patients with HER2 positive parenchymal brain metastatic breast cancer
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2015
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 24 Mar 2015 New trial record